Study Group: Physicians who Treat Primary Pulmonary Hypertension (US)(?)
Council Members in this Study Group: 103
Request a survey with this Study Group
Leading Experts in this Study Group
Ass. Professor in Medicine
University of North Carolina at Chapel Hill School of Medicine - CC
Ray Coakley, MD PhD, is a physician scientist / pulmonary & critical care specialist at the University of North Carolina, Chapel Hill. His clinical and research focus is on COPD, cystic fibrosis, lung transplantation and PAH. Specific research expertise includes airway epithelial ion/fluid transport...
Robert Aris, MDAssociate Professor of Medicine
University of North Carolina Chapel Hill - CC
Robert Aris, MD, is an Associate Professor of Medicine at the University of North Carolina Chapel Hill. He is the Director of the Pulmonary Hypertension Program, the Lung Transplant Research Program and Inpatient Pulmonary Services. Dr. Aris has expertise in advanced lung diseases including cystic...
President
PSS Clinical Research
Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies, and Co-Director of two sleep disorders centers...
Robyn Barst, MDFormerDirector
New York- Presbyterian/Columbia University Medical Center
Robyn J Barst, MD is Professor Emeritus of Pediatrics (in Medicine) at the College of Physicians and Surgeons at Columbia University. She was Director of the New York-Presbyterian Pulmonary Hypertension Center 1982-2008. She is a Fellow of the American Academy of Pediatrics, American College of Cardiology,...
Victor Tapson, MDMedical Director of Pulmonary Hypertension Center
Duke University
Victor Tapson, MD, is Professor of Medicine in the Division of Pulmonary and Critical Care at Duke University School of Medicine and the Medical Director of the Duke Pulmonary Hypertension Center. Dr. Tapson was Director for the Duke Lung Transplant Program for over 10 years and Director for the Center...
Assistant Professor & Director
University of Florida
Kamal Mubarak, MD, is an Assistant Professor and Director of the Pulmonary Vascular Disease Program at University of Florida, Gainesville. Dr. Mubarak's clinical specialties include Internal Medicine, Critical Care Medicine, and Pulmonary Disease. He is involved in numerous clinical trials in treating...
Inder Anand, MD, FACC, FRCP, DPhilDirector of the Heart Failure Program
Minneapolis VA Medical Center
Inder Anand, MD, FACC, FRCP, DPhil, is Professor of Medicine at the University of Minnesota. Dr. Anand is also Director of the Heart Failure Program at the Minneapolis VA Medical Center. Dr. Anand has expertise in pathophysiology and management of heart failure. He has been a principal investigator...
Associate Professor of Medicine
Stanford University Medical Center Auxiliary
Glenn Rosen, MD, is Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Stanford University with a joint appointment in Cancer Biology. Dr. Rosen has expertise in a wide variety of pulmonary diseases including lung cancer and pulmonary fibrosis. His basic research...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
VAD (ventricular-assisting devices) are definitely loosing popularity. The one of main reasons for that is extremely poor reimbursement. It is hard to make conclusions from the cited study. It is performed by Medicare. The average age of patients in the study was 63 years. Age over 65 is one of contraindications...
Heartburn and heart attack are two types of discomfort in the chest. Patients with coronary artery disease AND gastro-esophageal reflux disease often take PPI for chest pain and, therefore, tend to seek medical attention in more advanced stages of coronary artery disease.
This phase III study was done without the benefit of conventional drug development with Phase I and Phase II studies (which would have provided more information about the effective dose) preceding it because pharmacokinetic date from IV and SC dosing studies were used to extrapolate for the...
This collaboration will be very successful: the trial involving 20 000 patients will take a long time to complete. During the trial utilization of stents will not change. Upon completion of the trial it will become even more obvious that 2 years of "blood thinning" is better than 1 year for stents potency...
Amiodarone is still one of the best drugs for atrial fibrillation despite "rare incidence" of cirrhosis, lung fibrosis and now "rare muscle injury".
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Director
- Owner
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

